DiaMedica Therapeutics, Inc. (DMAC)
8.79
-0.54
(-5.79%)
USD |
NASDAQ |
Nov 13, 16:00
8.79
0.00 (0.00%)
After-Hours: 19:59
DiaMedica Therapeutics Price : 8.79 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 9.53 | 9.59 | 9.045 | 9.33 | 187771.0 |
| Nov 11, 2026 | 9.72 | 9.85 | 9.53 | 9.66 | 139358.0 |
| Nov 10, 2026 | 9.59 | 9.86 | 9.205 | 9.67 | 144932.0 |
| Nov 09, 2026 | 9.59 | 9.92 | 9.39 | 9.65 | 146710.0 |
| Nov 06, 2026 | 9.10 | 9.739 | 9.055 | 9.36 | 156755.0 |
| Nov 05, 2026 | 10.70 | 10.84 | 8.98 | 9.04 | 330471.0 |
| Nov 04, 2026 | 10.15 | 11.00 | 10.15 | 10.77 | 409096.0 |
| Nov 03, 2026 | 9.38 | 10.04 | 9.38 | 10.00 | 302504.0 |
| Nov 02, 2026 | 9.33 | 9.505 | 8.96 | 9.29 | 141536.0 |
| Oct 30, 2026 | 9.39 | 9.54 | 9.12 | 9.25 | 174648.0 |
| Oct 29, 2026 | 9.83 | 9.99 | 9.41 | 9.52 | 196511.0 |
| Oct 28, 2026 | 8.71 | 10.13 | 8.60 | 9.82 | 521281.0 |
| Oct 27, 2026 | 8.72 | 8.72 | 8.30 | 8.69 | 268715.0 |
| Oct 26, 2026 | 8.77 | 8.92 | 8.56 | 8.74 | 129604.0 |
| Oct 23, 2026 | 8.55 | 8.79 | 8.29 | 8.72 | 110029.0 |
| Oct 22, 2026 | 8.70 | 8.946 | 8.51 | 8.63 | 87988.00 |
| Oct 21, 2026 | 8.72 | 8.95 | 8.59 | 8.69 | 155378.0 |
| Oct 20, 2026 | 7.88 | 8.87 | 7.88 | 8.67 | 168169.0 |
| Oct 19, 2026 | 7.78 | 7.99 | 7.60 | 7.87 | 188583.0 |
| Oct 16, 2026 | 8.04 | 8.10 | 7.53 | 7.57 | 260779.0 |
| Oct 15, 2026 | 7.82 | 8.24 | 7.66 | 8.04 | 303895.0 |
| Oct 14, 2026 | 7.68 | 8.02 | 7.61 | 7.66 | 286962.0 |
| Oct 13, 2026 | 8.21 | 8.21 | 7.72 | 7.82 | 256052.0 |
| Oct 12, 2026 | 8.26 | 8.335 | 7.945 | 8.20 | 185593.0 |
| Oct 09, 2026 | 8.00 | 8.450 | 8.00 | 8.33 | 170152.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 47.76 |
| Nektar Therapeutics | 37.27 |
| Fortress Biotech, Inc. | 1.875 |
| ACADIA Pharmaceuticals, Inc. | 18.74 |
| Alnylam Pharmaceuticals, Inc. | 165.03 |
Price Related Metrics
| PEG Ratio | -3.586 |
| Price to Book Value | 12.36 |
| Earnings Yield | -8.12% |
| Market Cap | 474.01M |
| PEGY Ratio | -3.586 |